|
Index of reports
> Cases with Leukoencephalopathy (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ditropan (Oxybutynin) where reactions include leukoencephalopathy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ditropan side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-02
Patient: 72 year old female
Reactions: Confusional State, Iatrogenic Injury, Cerebral Atrophy, Cognitive Disorder, Parkinsonism, Leukoencephalopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xenazine
Start date: 2007-10-01
End date: 2010-03-01
Ditropan
Start date: 2007-11-01
End date: 2011-10-01
Azilect
Indication: Parkinsonism
Start date: 2011-07-01
End date: 2011-10-01
Cymbalta
Start date: 2009-11-01
End date: 2011-10-01
Exelon
Start date: 2011-09-01
End date: 2011-10-01
Possible Ditropan side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31
Patient: 72 year old female
Reactions: Cerebral Disorder, Iatrogenic Injury, Cerebral Atrophy, Cognitive Disorder, Leukoencephalopathy, Parkinsonism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ditropan
Start date: 2007-11-01
End date: 2011-10-01
Azilect
Indication: Parkinsonism
Start date: 2011-07-01
End date: 2011-10-01
Xenazine
Start date: 2007-10-01
End date: 2010-03-01
Cymbalta
Start date: 2009-11-01
End date: 2011-10-01
Exelon
Start date: 2011-09-01
End date: 2011-10-01
Possible Ditropan side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-05
Patient: female
Reactions: Confusional State, Iatrogenic Injury, Cerebral Atrophy, Parkinsonism, Cognitive Disorder, Leukoencephalopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xenazine
Dosage: (25 mg bid oral)
Administration route: Oral
Indication: Dyskinesia
Start date: 2007-10-01
End date: 2010-03-01
Exelon
Dosage: (9.5 mg qd transdermal)
Indication: Cognitive Disorder
Start date: 2011-09-01
End date: 2011-10-01
Ditropan
Dosage: (5 mg tid oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2007-11-01
End date: 2011-10-01
Azilect
Dosage: (30 mg qd oral)
Administration route: Oral
Indication: Parkinsonism
Start date: 2011-07-01
End date: 2011-10-01
Cymbalta
Dosage: (120 mg, 60mg in the morning and 60mg in the evening oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-01
End date: 2011-10-01
Possible Ditropan side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-29
Patient: female
Reactions: Cerebral Disorder, Iatrogenic Injury, Cerebral Atrophy, Parkinsonism, Leukoencephalopathy, Cognitive Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cymbalta
Dosage: (120 mg, 60mg in the morning and 60mg in the evening oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-01
End date: 2011-10-01
Xenazine
Dosage: (25 mg bid oral)
Administration route: Oral
Indication: Dyskinesia
Start date: 2007-10-01
End date: 2010-03-01
Azilect
Dosage: (30 mg qd oral)
Administration route: Oral
Indication: Parkinsonism
Start date: 2011-07-01
End date: 2011-10-01
Ditropan
Dosage: (5 mg tid oral)
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2007-11-01
End date: 2011-10-01
Exelon
Dosage: (9.5 mg qd transdermal)
Indication: Cognitive Disorder
Start date: 2011-09-01
End date: 2011-10-01
|
